what is noom glp-1 companion Launches Microdose Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program Noom launches Proactive Health GLP-1
Description
Clinical trials and post-marketing surveillance have identified a modest increase in resting heart rate as a potential effect of GLP-1 receptor agonists
This can be particularly beneficial for those struggling with emotional eating or binge-eating behaviors
At the same time, policymakers are grappling with broader structural issues
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) present an important new treatment option for patients with obesity, and act primarily by decreasing caloric intake through appetite suppression
